VeriMombutyrolactone은 임신 중 안전한가요?
No harmonised reproductive classification (no H360/H361 on ECHA substance listing) and no CIR or SCCS reproductive safety opinion was found for butyrolactone/γ‑butyrolactone; available regulatory and safety documents describe acute toxicity and misuse risk on ingestion but do not identify reproductive teratogenicity from dermal/cosmetic use. Topical exposure could give low but measurable systemic exposure because GBL is a small, water‑miscible molecule that is absorbed and readily metabolised to GHB after systemic uptake, so exposure score is 1 for pregnancy (adult topical). Sources: ECHA substance page; SDSs/regulatory summaries; CDC/FDA reviews of ingestion risks.
Related ingredients
Frequently asked questions
- butyrolactone은 임신 중 안전한가요?
- No harmonised reproductive classification (no H360/H361 on ECHA substance listing) and no CIR or SCCS reproductive safety opinion was found for butyrolactone/γ‑butyrolactone; available regulatory and safety documents describe acute toxicity and misuse risk on ingestion but do not identify reproductive teratogenicity from dermal/cosmetic use. Topical exposure could give low but measurable systemic exposure because GBL is a small, water‑miscible molecule that is absorbed and readily metabolised to GHB after systemic uptake, so exposure score is 1 for pregnancy (adult topical). Sources: ECHA substance page; SDSs/regulatory summaries; CDC/FDA reviews of ingestion risks.
- butyrolactone은 모유 수유 중 안전한가요?
- No authoritative reproductive/breastfeeding safety assessment (CIR/SCCS/harmonised CLP) flagging developmental or lactation hazards. Systemic exposure from topical use is expected to be low but measurable in adults; because GBL converts to GHB systemically, breastmilk transfer would only be a concern if significant maternal systemic levels occur (not typical from normal cosmetic topical use). Thus hazard/mechanism remain 0; exposure scored 1 (low but measurable). Sources: ECHA substance information; LactMed/GHB references and FDA/CDC warnings about systemic effects from ingestion rather than topical use.
- butyrolactone은 아기 피부에 안전한가요?
- No infant‑specific reproductive/developmental toxicity evidence from authoritative cosmetic safety bodies. Per scoring rules, because adult topical exposure is scored as 1 (measurable), infant skin exposure is increased by +1 (immature barrier and higher SA:BW) to give e=2 (moderate). There is no infant‑specific data showing placental or dermal developmental hazards; the main concern in literature is systemic GHB effects after ingestion/large exposures, not routine topical cosmetic use. Sources: ECHA substance page; EPA/EPA inert reassessment and SDSs describing routes of concern (ingestion/systemic), and EWG ingredient entry.
- VeriMom은 butyrolactone을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 butyrolactone을 93/100 (알려진 위험 없음)로 평가합니다.
- 임신 중 butyrolactone 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.